The long and short of metformin-related vitamin B12 deficiency [3]

Archives of Internal Medicine

Volumn 167, Issue 7, 2007, Pages 729-730

  Varughese, George I ^a   Tahrani, Abd A ^b   Scarpello, John H B ^b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; METFORMIN; PEPSIN A; PROTON PUMP INHIBITOR;

BACTERIAL GROWTH; CYANOCOBALAMIN DEFICIENCY; HUMAN; INTESTINE MOTILITY; LETTER; MALABSORPTION; MEDICAL RECORD; PEPSIN SECRETION; PRIORITY JOURNAL; RISK FACTOR; STOMACH ACID SECRETION; STOMACH PARIETAL CELL;

EID: 34247125147     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.7.729-b     Document Type: Letter

References (5)

1. 12 deficiency in patients receiving metformin. Arch Intern Med. 2006;166:1975-1979.
2. Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet Med. 1998;15:651-656.
3. Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S. Consumer usage patterns of nonprescription histamine2-receptor antagonists. Am J Gastroenterol. 2004;99:606-610.
4. Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006;20:1698-1701.
5. Varughese GI, Scarpello JH. Metformin and vitamin B12 deficiency: the role of H2 receptor antagonists and proton pump inhibitors. Age Ageing. 2007;36:110-111.